Clinical trial

A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal…

NCT00304642 · International Partnership for Microbicides, Inc., Industry · Completed

Key facts

NCT number NCT00304642
Title A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel
Official title A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel in Healthy HIV-Negative Women.
Lead sponsor International Partnership for Microbicides, Inc., Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions dapivirine (TMC120) vaginal gel
Enrollment 18
Start date Nov 1, 2005
First posted Mar 20, 2006
Last update posted Jun 2, 2006
Countries South Africa

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies